Patents by Inventor David House

David House has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120053150
    Abstract: The present invention relates to amide compounds, processes for their preparation, pharmaceutical compositions containing these compounds and to their use in the treatment of disorders, conditions or disorders such as allergic disorders, inflammatory disorders and disorders of the immune system.
    Type: Application
    Filed: April 22, 2010
    Publication date: March 1, 2012
    Inventors: David George Allen, Diane Mary Coe, Anthony William James Cooper, Paul Martin Gore, David House, Stefan Senger, Steven Leslie Sollis, Sadie Vile, Caroline Wilson
  • Publication number: 20120035237
    Abstract: The present invention relates to amide compounds, processes for their preparation, intermediates usable in these processes, pharmaceutical compositions containing these compounds and to their use in therapy.
    Type: Application
    Filed: April 22, 2010
    Publication date: February 9, 2012
    Inventors: Diane Mary Coe, Anthony William James Cooper, Paul Martin Gore, David House, Stefan Senger, Sadie Vile
  • Patent number: 8093281
    Abstract: A compound of formula (I): wherein A1 represents 2,3-dihydro-1-benzofuran-7-yl, 5-fluoro-2-methoxy-phenyl or 5-fluoro-2-hydroxy-phenyl; X represents —C(R3)— or nitrogen; when X represents —C(R3)—, R2 represents hydrogen and R1 represents fluorine, R3 represents hydrogen or fluorine, when X represents —C(R3)— and R2 and R1 each represent hydrogen, R3 represents hydrogen, hydroxy, methoxy or fluorine, when X represents —C(R3)— and R2 represents hydroxy, methoxy, —CO2CH3 or —CO2CH2CH3, R1 and R3 each represent hydrogen, when X represents nitrogen, R1 and R2 each represent hydrogen; and Y represents H or methyl; or a physiologically functional derivative thereof.
    Type: Grant
    Filed: April 12, 2006
    Date of Patent: January 10, 2012
    Assignee: Glaxo Group Limited
    Inventors: Colin David Eldred, David House, Graham George Adam Inglis, Simon John Fawcett MacDonald, Philip Alan Skone
  • Patent number: 7947727
    Abstract: The present invention provides compounds of formula (I): a process for their preparation, pharmaceutical compositions comprising the compounds and the preparation of said compositions, intermediates and use of the compounds for the manufacture of a medicament for therapeutic treatment, particularly for the treatment of inflammation, allergy and/or skin disease.
    Type: Grant
    Filed: October 10, 2007
    Date of Patent: May 24, 2011
    Assignee: GlaxoGroupLimited
    Inventors: Keith Biggadike, Anthony William James Cooper, David House, Simon John Fawcett MacDonald, Philip Alan Skone, Gordon Gad Weingarten
  • Patent number: 7943651
    Abstract: The present invention provides compounds of formula (I): pharmaceutical compositions comprising the compounds and the use of the compounds for the manufacture of a medicament, particularly for the treatment of inflammation and/or allergic conditions.
    Type: Grant
    Filed: April 18, 2007
    Date of Patent: May 17, 2011
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Anthony William James Cooper, David House, Iain McFarlane McLay
  • Publication number: 20100120883
    Abstract: The present invention provides compounds of formula (I): a process for their preparation, pharmaceutical compositions comprising the compounds and the preparation of said compositions, intermediates and use of the compounds for the manufacture of a medicament for therapeutic treatment, particularly for the treatment of inflammation, allergy and/or skin disease.
    Type: Application
    Filed: October 10, 2007
    Publication date: May 13, 2010
    Inventors: Keith Biggadike, Anthony William James Cooper, David House, Simon John Fawcett MacDonald, Philip Alan Skone, Gordon Gad Weingarten
  • Publication number: 20100016331
    Abstract: The present invention provides compounds of formula (I): a process for their preparation, pharmaceutical compositions comprising the compounds and the preparation of said compositions, intermediates and use of the compounds for the manufacture of a medicament for therapeutic treatment, particularly for the treatment of inflammation, allergy and/or skin disease.
    Type: Application
    Filed: October 10, 2007
    Publication date: January 21, 2010
    Inventors: Keith Biggadike, Anthony William James Cooper, David House, Iain McFarlane McLay
  • Publication number: 20090111866
    Abstract: The present invention provides compounds of formula (I): pharmaceutical compositions comprising the compounds and the use of the compounds for the manufacture of a medicament, particularly for the treatment of inflammation and/or allergic conditions.
    Type: Application
    Filed: April 18, 2007
    Publication date: April 30, 2009
    Applicant: Glaxo Wellcome House
    Inventors: Keith Biggadike, Anthony William James Cooper, David House, Iain McFarlane McLay, Grahame Robert Woollam
  • Publication number: 20090074675
    Abstract: A compound of formula (I): wherein A1 represents 2,3-dihydro-1-benzofuran-7-yl, 5-fluoro-2-methoxy-phenyl or 5-fluoro-2-hydroxy-phenyl; X represents —C(R3)— or nitrogen; when X represents —C(R3)—, R2 represents hydrogen and R1 represents fluorine, R3 represents hydrogen or fluorine, when X represents —C(R3)— and R2 and R1 each represent hydrogen, R3 represents hydrogen, hydroxy, methoxy or fluorine, when X represents —C(R3)— and R2 represents hydroxy, methoxy, —CO2CH3 or —CO2CH2CH3, R1 and R3 each represent hydrogen, when X represents nitrogen, R1 and R2 each represent hydrogen; and Y represents H or methyl; or a physiologically functional derivative thereof.
    Type: Application
    Filed: April 12, 2006
    Publication date: March 19, 2009
    Applicant: GLAXO GROUP LIMITED
    Inventors: Colin David Eldred, David House, Graham George Adam Inglis, Simon John Fawcett MacDonald, Philip Alan Skone
  • Publication number: 20080292561
    Abstract: A compound of formula (I): is claimed wherein A represents 2,3-dihydro-1-benzofuran-7-yl, 5-fluoro-2-methoxy-phenyl or 5-fluoro-2-hydroxy-phenyl; R1 represents phenyl, pyridyl or thienyl wherein the phenyl group may be optionally substituted by one or two groups independently selected from fluorine, cyano, —C(O)OCH3 and —C(O)OCH2CH3, and the pyridyl group may be optionally substituted by one fluorine group; and R2 represents methyl or ethyl; along with physiologically functional derivatives thereof, pharmaceutical compositions and formulations thereof, combinations thereof, methods of treatment employing such compounds and processes for preparing the compounds.
    Type: Application
    Filed: November 7, 2006
    Publication date: November 27, 2008
    Inventors: Keith Biggadike, David House, Graham George Adam Inglis, Simon John Fawcett MacDonald, Iain McFarlane McLay, Philip Alan Skone
  • Publication number: 20080207725
    Abstract: A compound of formula (I): wherein A represents 2,3-dihydro-1-benzofuran-7-yl, 5-fluoro-2-methoxy-phenyl or 5-fluoro-2-hydroxy-phenyl; and R1 and R2 each independently represent hydrogen, fluorine or chlorine; or a physiologically functional derivative thereof.
    Type: Application
    Filed: June 27, 2006
    Publication date: August 28, 2008
    Inventors: Michael David Barker, David House, Haydn Terence Jones, Simon John Fawcett MacDonald, Iain McFarlane Mclay
  • Publication number: 20070265326
    Abstract: The present invention provides compounds of formula (I): pharmaceutical compositions comprising the compounds and the use of the compounds for the manufacture of a medicament, particularly for the treatment of inflammation and/or allergic conditions.
    Type: Application
    Filed: April 18, 2007
    Publication date: November 15, 2007
    Applicant: GLAXO GROUP LIMITED
    Inventors: Keith BIGGADIKE, Anthony COOPER, David HOUSE, Iain MCLAY, Grhame Woollam
  • Publication number: 20030154127
    Abstract: A method and apparatus is disclosed for tracking the buying and selling of a manufacturer's goods or products where the manufacturer may receive an incentive from the sale of the manufacturer's goods or products by other sellers. A manufacturer may have one or more incentive programs that may apply to goods sold or otherwise transferred. The method and apparatus may determine the incentive program that may apply and determine the incentive due the manufacturer.
    Type: Application
    Filed: February 12, 2002
    Publication date: August 14, 2003
    Inventors: Barry S. McAuliffe, David A. House, Benjamin J. Weisshaut, Jeffrey G. Ichnowski